Literature DB >> 18279975

Ototopical antifungals and otomycosis: a review.

Raymundo Munguia1, Sam J Daniel.   

Abstract

There has been an increase in the prevalence of otomycosis in recent years. This has been linked to the extensive use of antibiotic eardrops. Treatment of otomycosis is challenging, and requires a close follow-up. We present a review of the literature on otomycosis, the topical antifungals most commonly used, and discuss their ototoxic potential. Candida albicans and Aspergillus are the most commonly identified organisms. Antifungals from the Azole class seem to be the most effective, followed by Nystatin and Tolnaftate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18279975     DOI: 10.1016/j.ijporl.2007.12.005

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  36 in total

1.  Topical treatment of chronic suppurative otitis media.

Authors:  Sam J Daniel
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

2.  Otomycosis due to filamentous fungi.

Authors:  Lidia García-Agudo; Pilar Aznar-Marín; Fátima Galán-Sánchez; Pedro García-Martos; Pilar Marín-Casanova; Manuel Rodríguez-Iglesias
Journal:  Mycopathologia       Date:  2011-04-17       Impact factor: 2.574

3.  [Pruritus, erythema and others. Dermatology of the ear].

Authors:  E Weisshaar; U Kallen; N Klintworth; J Zenk
Journal:  HNO       Date:  2011-03       Impact factor: 1.284

Review 4.  Otomycosis in iran: a review.

Authors:  Maral Gharaghani; Zahra Seifi; Ali Zarei Mahmoudabadi
Journal:  Mycopathologia       Date:  2015-01-30       Impact factor: 2.574

5.  Otomycosis in central iran: a clinical and mycological study.

Authors:  B Barati; S A R Okhovvat; A Goljanian; M R Omrani
Journal:  Iran Red Crescent Med J       Date:  2011-12-01       Impact factor: 0.611

6.  Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis.

Authors:  Keyvan Kiakojuri; Saeid Mahdavi Omran; Somayeh Roodgari; Mojtaba Taghizadeh Armaki; Mohammad Taghi Hedayati; Tahereh Shokohi; Iman Haghani; Javad Javidnia; Firoozeh Kermani; Hamid Badali; Mahdi Abastabar
Journal:  Mycopathologia       Date:  2021-03-15       Impact factor: 2.574

7.  Type of Antifungals: Does it Matter in Empirical Treatment of Otomycosis?

Authors:  Nagendran Navaneethan; Raj Prakash Dharmapuri YaadhavaKrishnan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-10-04

8.  Otomycosis in Jos: Predisposing factors and Management.

Authors:  A S Adoga; A A Iduh
Journal:  Afr J Med Med Sci       Date:  2014-09

9.  Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents.

Authors:  Shadman Nemati; Rasool Hassanzadeh; Sina Khajeh Jahromi; Azimeh Delkhosh Nasrollah Abadi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-18       Impact factor: 2.503

10.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.